Newsletters

Germany passes DTx formulary, payment law. Outcomes over Exits?

7.11.19

6 min. Read

Livongo clients mostly small commercial pilots? FDA easing.

7.02.19

6 min. Read

Omada’s strategy. Boehringer invests in myopia DTx.

6.27.19

6 min. Read

Digital health formulary wars heat up. $40M price tag for a digital drug.

6.20.19

7 min. Read

Express Scripts talks but CVS launches. India’s 4,800 health startups.

6.13.19

4 min. Read

Virta Health study. FDA-cleared algorithms. Arthritis DTx.

6.06.19

6 min. Read

Facebook Health. Apple Asthma. Blue Note.

5.30.19

6 min. Read

FDA Pre-Cert Dropouts? NightWare for Nightmares. Amazon wearable.

5.24.19

3 min. Read

Omada User Growth. Apple Work Experience. European DTx.

5.16.19

4 min. Read

Going Global. Khosla-AliveCor. Propeller Strategy.

5.09.19

5 min. Read